David Liu (Rose Lincoln/Harvard Staff Photographer)

Out of CRISPR pi­o­neer David Li­u's lab comes a small mol­e­cule play tar­get­ing ex­osites — and it's raised a mod­est $25M to push to­ward clin­ic

David Liu may be best known as a CRISPR trail­blaz­er be­hind Ed­i­tas Med­i­cine, Beam Ther­a­peu­tics and Prime Med­i­cine. But more than six years ago, he …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.